![](https://www.worldpharmatoday.com/images/nBanners/Docuvera-728x90.jpeg")
Clinical Trials
AstraZeneca Phase I clinical trial initiated for COVID-19 monoclonal antibody
The first participants have been dosed in a Phase I trial of AZD7442, a combination of two monoclonal antibodies (mAbs) in development for the...
Drug Research
AbbVie, Harvard University Form Research Alliance to Address Emergent Viral Diseases
AbbVie and Harvard University announced a $30 million collaborative research alliance, launching a multi-pronged effort at Harvard Medical School (HMS) to study and develop...
News
Bristol Myers Squibb Enters Agreement to Acquire Forbius, Adding Lead TGF-beta Asset to Portfolio
Bristol Myers Squibb and Forbius, a privately held, clinical-stage protein engineering company that designs and develops biotherapeutics for the treatment of cancer and fibrotic...
Clinical Trials
BMS Provides Update on Phase 3 IDHENTIFY Trial in Patients with Relapsed or Refractory Acute Myeloid Leukemia
Bristol Myers Squibb announced that the Phase 3 IDHENTIFY study evaluating IDHIFA® (enasidenib) plus best supportive care (BSC) versus conventional care regimens, which include...
Press Releases
Mitsubishi Tanabe Pharma Launch of VAFSEO,for the treatment of renal anemia in Japan
Mitsubishi Tanabe Pharma Corporation announced that MTPC is launchingVAFSEO®Tablets 150mg and 300mg (VAFSEO®, vadadustat) which is anoralhypoxia-inducible factor prolyl hydroxylase (HIF-PH) inhibitor in-licensed from...
Press Releases
Thermo Fisher Scientific Introduces Hematology-Oncology Portfolio for Ion Torrent Genexus System
In hematology oncology, it is critically important to understand the genetics driving acute malignancies to quickly determine how best to address the disease. Today,...
Drug Research
Quanticate Announces new Partnership with Antev Ltd
Quanticate is pleased to partner with Antev Limited on a Phase II, Open-Label, Multicentre Study Investigating the Pharmacokinetics, Pharmacodynamics, Efficacy and Safety of Teverelix...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read